These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 31796890)

  • 1. Opportunities for pharmacists to integrate pharmacogenomics into clinical practice.
    Wang YT; Merl MY; Yang J; Zhu ZX; Li GH
    Pharmacogenomics J; 2020 Apr; 20(2):169-178. PubMed ID: 31796890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenomics in a community pharmacy: ACT now.
    Padgett L; O'Connor S; Roederer M; McLeod H; Ferreri S
    J Am Pharm Assoc (2003); 2011; 51(2):189-93. PubMed ID: 21382809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists.
    Alexander KM; Divine HS; Hanna CR; Gokun Y; Freeman PR
    J Am Pharm Assoc (2003); 2014; 54(5):510-7, 5 p following 517. PubMed ID: 25148656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
    Reiss SM;
    J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
    Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
    J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a pharmacogenomics service in a community pharmacy.
    Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
    J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementation of targeted medication adherence interventions within a community chain pharmacy practice: The Pennsylvania Project.
    Bacci JL; McGrath SH; Pringle JL; Maguire MA; McGivney MS
    J Am Pharm Assoc (2003); 2014; 54(6):584-93. PubMed ID: 25379980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perceptions of patients on Medicare Part D medication therapy management services.
    Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
    J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community pharmacists' educational needs for implementing clinical pharmacogenomic services.
    Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE
    J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine.
    Schwartz EJ; Issa AM
    Per Med; 2017 Jan; 14(1):27-35. PubMed ID: 29749827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community pharmacists' experience with pharmacogenetic testing.
    Moaddeb J; Mills R; Haga SB
    J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ready or not, here it comes: Direct-to-consumer pharmacogenomic testing and its implications for community pharmacists.
    Gammal RS; Mayes J; Caudle KE
    J Am Pharm Assoc (2003); 2019; 59(5):646-650. PubMed ID: 31327749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the current level of pharmacists' pharmacogenomics knowledge and its impact on pharmacogenomics implementation.
    Nagy M; Tsermpini EE; Siamoglou S; Patrinos GP
    Pharmacogenomics; 2020 Nov; 21(16):1179-1189. PubMed ID: 33118449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles for pharmacists in clinical implementation of pharmacogenomics.
    Owusu-Obeng A; Weitzel KW; Hatton RC; Staley BJ; Ashton J; Cooper-Dehoff RM; Johnson JA
    Pharmacotherapy; 2014 Oct; 34(10):1102-12. PubMed ID: 25220280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
    Papastergiou J; Tolios P; Li W; Li J
    J Am Pharm Assoc (2003); 2017; 57(5):624-629. PubMed ID: 28689706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies and steps fostering the success of medication management services in community pharmacies.
    Pestka DL; Frail CK; Palombi LC; Von Hoff BA; Conway JM; Sorensen TD
    J Am Pharm Assoc (2003); 2016; 56(5):504-512.e1. PubMed ID: 27498311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication therapy management services in West Virginia: pharmacists' perceptions of educational and training needs.
    Blake KB; Madhavan SS; Scott VG; Meredith Elswick BL
    Res Social Adm Pharm; 2009 Jun; 5(2):182-8. PubMed ID: 19524865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for community-based medication management services in value-based health plans.
    Smith MA; Spiggle S; McConnell B
    Res Social Adm Pharm; 2017; 13(1):48-62. PubMed ID: 26904962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists.
    MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K
    J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.